2025 INOVIO Stock Forecast: Will It Reach $20?
The way forward for Inovio Prescribed drugs, Inc. (NASDAQ: INO) inventory is a subject of nice curiosity to buyers. The corporate is a clinical-stage biopharmaceutical firm creating DNA-based immunotherapies for the remedy of most cancers and infectious ailments. Inovio’s lead product candidate is VGX-3100, a DNA-based immunotherapy for the remedy of cervical most cancers. The … Read more